↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Olsson H) ;conttype:(refereed)"

Search: WFRF:(Olsson H) > Peer-reviewed

Result 1-10 of 1411

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Corbalan, R, et al. (author) Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry 2019 In: JAMA cardiology. - : American Medical Association (AMA). - 2380-6591 .- 2380-6583. ; 4:6, s. 526-548 Journal article (peer-reviewed)
2.	Bonaca, MP, et al. (author) Long-term use of ticagrelor in patients with prior myocardial infarction 2015 In: The New England journal of medicine. - 1533-4406. ; 372:19, s. 1791-1800 Journal article (peer-reviewed)
3.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
4.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
5.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
6.	Steg, PG, et al. (author) Effect of Alirocumab on Mortality After Acute Coronary Syndromes 2019 In: Circulation. - 1524-4539. ; 140:2, s. 103-112 Journal article (peer-reviewed)
7.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
8.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
9.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)
10.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 1411

Refine your search

Type of publication: journal article (1264); conference paper (123); research review (17); book chapter (6); reports (1)

Type of content: peer-reviewed (1411)Undo refine

Author/Editor: Olsson, H. (159); Zhang, Z. (117); Meyer, J. (108); Schmitt, S. (108); Olsson, T (107); Rizvi, E. (106); show more...; South, D. (106); Diaconu, C. (106); Ferencei, J. (106); Greenshaw, T. (106); Lebedev, A. (106); Levonian, S. (106); Andreev, V. (106); Belousov, A. (106); Boudry, V. (106); Brisson, V. (106); Cvach, J. (106); Dodonov, V. (106); Eckerlin, G. (106); Egli, S. (106); Favart, L. (106); Fedotov, A. (106); Gabathuler, E. (106); Ghazaryan, S. (106); Goerlich, L. (106); Gogitidze, N. (106); Grab, C. (106); Horisberger, R. (106); Kapichine, M. (106); Kiesling, C. (106); Lubimov, V. (106); Malinovski, E. (106); Meyer, H. (106); Niebuhr, C. (106); Nowak, G. (106); Pascaud, C. (106); Perez, E. (106); Pitzl, D. (106); Roosen, R. (106); Rostovtsev, A. (106); Soloviev, Y. (106); Spaskov, V. (106); Specka, A. (106); Stella, B. (106); Straumann, U. (106); Traynor, D. (106); Turnau, J. (106); Vallee, C. (106); Vazdik, Y. (106); Zalesak, J. (106); show less...

University: Karolinska Institutet (539); Lund University (529); Uppsala University (290); University of Gothenburg (191); Umeå University (101); Linköping University (78); show more...; Chalmers University of Technology (77); Royal Institute of Technology (59); Örebro University (25); Stockholm University (22); Swedish University of Agricultural Sciences (22); RISE (13); Kristianstad University College (12); Luleå University of Technology (10); University of Borås (9); Karlstad University (9); Jönköping University (8); Mid Sweden University (8); Linnaeus University (7); University of Gävle (5); Malmö University (5); Swedish Museum of Natural History (5); Halmstad University (3); University West (3); Mälardalen University (3); Södertörn University (3); Högskolan Dalarna (3); Stockholm School of Economics (2); The Swedish School of Sport and Health Sciences (2); Blekinge Institute of Technology (2); Marie Cederschiöld högskola (2); Sophiahemmet University College (1); show less...

Language: English (1400); Swedish (10); Undefined language (1)

Research subject (UKÄ/SCB): Medical and Health Sciences (560); Natural sciences (333); Engineering and Technology (90); Agricultural Sciences (24); Social Sciences (23); Humanities (4)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view